サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1385381

世界のRNA治療薬とワクチン市場：考察と予測 (2029年まで)

Global RNA Therapeutics and Vaccines Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 118 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界のRNA治療薬とワクチン市場：考察と予測 (2029年まで)
出版日: 2023年11月27日
発行: QYResearch
ページ情報: 英文 118 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、RNA治療薬とワクチン (RNA Therapeutics and Vaccines) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • RNA治療薬とワクチンの製品概要
  • 市場：タイプ別
    • 世界のRNA治療薬とワクチンの市場規模成長率：タイプ別, 2018 VS 2022 VS 2029
    • mRNA (messenger RNA) Therapeutics
    • siRNA (small interfering RNA) Therapeutics
    • Antisense Oligonucleotide Therapeutics
  • 市場：用途別
    • 世界のRNA治療薬とワクチンの市場規模成長率：用途別, 2018 VS 2022 VS 2029
    • Hospitals
    • Research Institutions
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界のRNA治療薬とワクチン売上予測・予想 2018-2029
  • 世界のRNA治療薬とワクチンの収益：地域別
    • 世界のRNA治療薬とワクチンの収益：地域別: 2018 VS 2022 VS 2029
    • 世界のRNA治療薬とワクチンの収益：地域別 (2018-2023)
    • 世界のRNA治療薬とワクチンの収益：地域別 (2024-2029)
    • 世界のRNA治療薬とワクチンの収益市場シェア 地域別 (2018-2029)
  • 世界のRNA治療薬とワクチン売上予測・予想 2018-2029
  • 世界のRNA治療薬とワクチンの販売：地域別
    • 世界のRNA治療薬とワクチンの販売：地域別: 2018 VS 2022 VS 2029
    • 世界のRNA治療薬とワクチンの販売：地域別 (2018-2023)
    • 世界のRNA治療薬とワクチンの販売：地域別 (2024-2029)
    • 世界のRNA治療薬とワクチンの販売市場シェア 地域別 (2018-2029)
  • 米国・カナダ
  • 欧州
  • 中国
  • アジア（中国を除く）
  • 中東, アフリカ ・ラテンアメリカ

第3章 競合：企業別

  • 世界のRNA治療薬とワクチンの販売：企業別
    • 世界のRNA治療薬とワクチンの販売：企業別 (2018-2023)
    • 世界のRNA治療薬とワクチンの販売市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： RNA治療薬とワクチン in 2022
  • 世界のRNA治療薬とワクチンの収益：企業別
    • 世界のRNA治療薬とワクチンの収益：企業別 (2018-2023)
    • 世界のRNA治療薬とワクチンの収益市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： RNA治療薬とワクチンの収益 2022
  • 世界の主要企業 RNA治療薬とワクチン, 業界ランキング, 2021 VS 2022 VS 2023
  • 世界のRNA治療薬とワクチンの販売価格：企業別
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界のRNA治療薬とワクチンの市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー RNA治療薬とワクチン, 製造拠点分布と本社
  • 世界の主要メーカー RNA治療薬とワクチン, 提供製品と用途
  • 世界の主要メーカー RNA治療薬とワクチン, 業界参入時期
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界のRNA治療薬とワクチンの販売：タイプ別
    • 世界のRNA治療薬とワクチンの販売実績：タイプ別 (2018-2023)
    • 世界のRNA治療薬とワクチンの販売予測：タイプ別 (2024-2029)
    • 世界のRNA治療薬とワクチンの販売市場シェア：タイプ別 (2018-2029)
  • 世界のRNA治療薬とワクチン 収益：タイプ別
    • 世界のRNA治療薬とワクチンの収益実績：タイプ別 (2018-2023)
    • 世界のRNA治療薬とワクチンの収益予測：タイプ別 (2024-2029)
    • 世界のRNA治療薬とワクチンの収益市場シェア：タイプ別 (2018-2029)
  • 世界のRNA治療薬とワクチンの価格：タイプ別
    • 世界のRNA治療薬とワクチンの価格：タイプ別 (2018-2023)
    • 世界のRNA治療薬とワクチンの価格予測：タイプ別 (2024-2029)

第5章 市場規模：用途別

  • 世界のRNA治療薬とワクチンの販売：用途別
    • 世界のRNA治療薬とワクチンの販売実績：用途別 (2018-2023)
    • 世界のRNA治療薬とワクチンの販売予測：用途別 (2024-2029)
    • 世界のRNA治療薬とワクチンの販売市場シェア：用途別 (2018-2029)
  • 世界のRNA治療薬とワクチンの収益：用途別
    • 世界のRNA治療薬とワクチンの収益実績：用途別 (2018-2023)
    • 世界のRNA治療薬とワクチンの収益予測：用途別 (2024-2029)
    • 世界のRNA治療薬とワクチンの収益市場シェア：用途別 (2018-2029)
  • 世界のRNA治療薬とワクチンの価格：用途別
    • 世界のRNA治療薬とワクチンの価格：用途別 (2018-2023)
    • 世界のRNA治療薬とワクチンの価格予測：用途別 (2024-2029)

第6章 米国・カナダ

  • 米国・カナダ RNA治療薬とワクチン 市場規模：タイプ別
    • 米国・カナダ RNA治療薬とワクチンの販売：タイプ別 (2018-2029)
    • 米国・カナダ RNA治療薬とワクチン 収益：タイプ別 (2018-2029)
  • 米国・カナダ RNA治療薬とワクチン 市場規模：用途別
    • 米国・カナダ RNA治療薬とワクチンの販売：用途別 (2018-2029)
    • 米国・カナダ RNA治療薬とワクチンの収益：用途別 (2018-2029)
  • 米国・カナダ RNA治療薬とワクチン 市場規模：国別
    • 米国・カナダ RNA治療薬とワクチンの収益：国別: 2018 VS 2022 VS 2029
    • 米国・カナダ RNA治療薬とワクチンの販売：国別 (2018-2029)
    • 米国・カナダ RNA治療薬とワクチンの収益：国別 (2018-2029)
    • US
    • カナダ

第7章 欧州

  • 欧州のRNA治療薬とワクチン 市場規模：タイプ別
    • 欧州のRNA治療薬とワクチンの販売：タイプ別 (2018-2029)
    • 欧州のRNA治療薬とワクチン 収益：タイプ別 (2018-2029)
  • 欧州のRNA治療薬とワクチン 市場規模：用途別
    • 欧州のRNA治療薬とワクチンの販売：用途別 (2018-2029)
    • 欧州のRNA治療薬とワクチンの収益：用途別 (2018-2029)
  • 欧州のRNA治療薬とワクチン 市場規模：国別
    • 欧州のRNA治療薬とワクチンの収益：国別: 2018 VS 2022 VS 2029
    • 欧州のRNA治療薬とワクチンの販売：国別 (2018-2029)
    • 欧州のRNA治療薬とワクチンの収益：国別 (2018-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 中国

  • 中国のRNA治療薬とワクチン 市場規模
    • 中国のRNA治療薬とワクチン 売上 (2018-2029)
    • 中国のRNA治療薬とワクチン 収益 (2018-2029)
  • 中国のRNA治療薬とワクチン 市場規模：用途別
    • 中国のRNA治療薬とワクチンの販売：用途別 (2018-2029)
    • 中国のRNA治療薬とワクチンの収益：用途別 (2018-2029)

第9章 アジア（中国を除く）

  • アジア地域 RNA治療薬とワクチン 市場規模：タイプ別
    • アジア地域 RNA治療薬とワクチンの販売：タイプ別 (2018-2029)
    • アジア地域 RNA治療薬とワクチン 収益：タイプ別 (2018-2029)
  • アジア地域 RNA治療薬とワクチン 市場規模：用途別
    • アジア地域 RNA治療薬とワクチンの販売：用途別 (2018-2029)
    • アジア地域 RNA治療薬とワクチンの収益：用途別 (2018-2029)
  • アジア地域 RNA治療薬とワクチンの販売：地域別
    • アジア地域 RNA治療薬とワクチンの収益：地域別: 2018 VS 2022 VS 2029
    • アジア地域 RNA治療薬とワクチンの収益：地域別 (2018-2029)
    • アジア地域 RNA治療薬とワクチンの販売：地域別 (2018-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド

第10章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカのRNA治療薬とワクチン 市場規模：タイプ別
    • 中東, アフリカ ・ラテンアメリカのRNA治療薬とワクチンの販売：タイプ別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカのRNA治療薬とワクチン 収益：タイプ別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカのRNA治療薬とワクチン 市場規模：用途別
    • 中東, アフリカ ・ラテンアメリカのRNA治療薬とワクチンの販売：用途別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカのRNA治療薬とワクチンの収益：用途別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカのRNA治療薬とワクチンの販売：国別
    • 中東, アフリカ ・ラテンアメリカのRNA治療薬とワクチンの収益：国別: 2018 VS 2022 VS 2029
    • 中東, アフリカ ・ラテンアメリカのRNA治療薬とワクチンの収益：国別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカのRNA治療薬とワクチンの販売：国別 (2018-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第11章 企業プロファイル

  • Moderna
  • BioNTech (Pfizer)
  • Sanofi
  • Novartis
  • CureVac
  • CSL
  • Arrowhead Pharmaceuticals
  • Alnylam Pharmaceuticals
  • GlaxoSmithKline (GSK)
  • Ionis Pharmaceuticals
  • Regulus Therapeutics
  • Roche
  • AstraZeneca
  • Sarepta Therapeutics
  • Orna Therapeutics

第12章 業界チェーンと販売チャネルの分析

  • RNA治療薬とワクチン 業界チェーン分析
  • RNA治療薬とワクチン 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • RNA治療薬とワクチン 生産形態とプロセス
  • RNA治療薬とワクチン 販売およびマーケティング
    • RNA治療薬とワクチン 販売チャネルs
    • RNA治療薬とワクチン 卸業者
  • RNA治療薬とワクチン 顧客

第13章 市場動向

  • RNA治療薬とワクチン 業界動向
  • RNA治療薬とワクチン 市場の促進要因
  • RNA治療薬とワクチン 市場の課題
  • RNA治療薬とワクチン 市場の抑制要因

第14章 主な調査結果 世界のRNA治療薬とワクチンの主な市場調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global RNA Therapeutics and Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Major Manufacturers of mRNA (messenger RNA) Therapeutics
  • Table 3. Major Manufacturers of siRNA (small interfering RNA) Therapeutics
  • Table 4. Major Manufacturers of Antisense Oligonucleotide Therapeutics
  • Table 5. Global RNA Therapeutics and Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 6. Global RNA Therapeutics and Vaccines Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 7. Global RNA Therapeutics and Vaccines Revenue by Region (2018-2023) & (US$ Million)
  • Table 8. Global RNA Therapeutics and Vaccines Revenue by Region (2024-2029) & (US$ Million)
  • Table 9. Global RNA Therapeutics and Vaccines Revenue Market Share by Region (2018-2023)
  • Table 10. Global RNA Therapeutics and Vaccines Revenue Market Share by Region (2024-2029)
  • Table 11. Global RNA Therapeutics and Vaccines Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 12. Global RNA Therapeutics and Vaccines Sales by Region (2018-2023) & (K Units)
  • Table 13. Global RNA Therapeutics and Vaccines Sales by Region (2024-2029) & (K Units)
  • Table 14. Global RNA Therapeutics and Vaccines Sales Market Share by Region (2018-2023)
  • Table 15. Global RNA Therapeutics and Vaccines Sales Market Share by Region (2024-2029)
  • Table 16. Global RNA Therapeutics and Vaccines Sales by Manufacturers (2018-2023) & (K Units)
  • Table 17. Global RNA Therapeutics and Vaccines Sales Share by Manufacturers (2018-2023)
  • Table 18. Global RNA Therapeutics and Vaccines Revenue by Manufacturers (2018-2023) & (US$ Million)
  • Table 19. Global RNA Therapeutics and Vaccines Revenue Share by Manufacturers (2018-2023)
  • Table 20. Global Key Players of RNA Therapeutics and Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
  • Table 21. RNA Therapeutics and Vaccines Price by Manufacturers 2018-2023 (US$/Unit)
  • Table 22. Global RNA Therapeutics and Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 23. Global RNA Therapeutics and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Therapeutics and Vaccines as of 2022)
  • Table 24. Global Key Manufacturers of RNA Therapeutics and Vaccines, Manufacturing Base Distribution and Headquarters
  • Table 25. Global Key Manufacturers of RNA Therapeutics and Vaccines, Product Offered and Application
  • Table 26. Global Key Manufacturers of RNA Therapeutics and Vaccines, Date of Enter into This Industry
  • Table 27. Mergers & Acquisitions, Expansion Plans
  • Table 28. Global RNA Therapeutics and Vaccines Sales by Type (2018-2023) & (K Units)
  • Table 29. Global RNA Therapeutics and Vaccines Sales by Type (2024-2029) & (K Units)
  • Table 30. Global RNA Therapeutics and Vaccines Sales Share by Type (2018-2023)
  • Table 31. Global RNA Therapeutics and Vaccines Sales Share by Type (2024-2029)
  • Table 32. Global RNA Therapeutics and Vaccines Revenue by Type (2018-2023) & (US$ Million)
  • Table 33. Global RNA Therapeutics and Vaccines Revenue by Type (2024-2029) & (US$ Million)
  • Table 34. Global RNA Therapeutics and Vaccines Revenue Share by Type (2018-2023)
  • Table 35. Global RNA Therapeutics and Vaccines Revenue Share by Type (2024-2029)
  • Table 36. RNA Therapeutics and Vaccines Price by Type (2018-2023) & (US$/Unit)
  • Table 37. Global RNA Therapeutics and Vaccines Price Forecast by Type (2024-2029) & (US$/Unit)
  • Table 38. Global RNA Therapeutics and Vaccines Sales by Application (2018-2023) & (K Units)
  • Table 39. Global RNA Therapeutics and Vaccines Sales by Application (2024-2029) & (K Units)
  • Table 40. Global RNA Therapeutics and Vaccines Sales Share by Application (2018-2023)
  • Table 41. Global RNA Therapeutics and Vaccines Sales Share by Application (2024-2029)
  • Table 42. Global RNA Therapeutics and Vaccines Revenue by Application (2018-2023) & (US$ Million)
  • Table 43. Global RNA Therapeutics and Vaccines Revenue by Application (2024-2029) & (US$ Million)
  • Table 44. Global RNA Therapeutics and Vaccines Revenue Share by Application (2018-2023)
  • Table 45. Global RNA Therapeutics and Vaccines Revenue Share by Application (2024-2029)
  • Table 46. RNA Therapeutics and Vaccines Price by Application (2018-2023) & (US$/Unit)
  • Table 47. Global RNA Therapeutics and Vaccines Price Forecast by Application (2024-2029) & (US$/Unit)
  • Table 48. US & Canada RNA Therapeutics and Vaccines Sales by Type (2018-2023) & (K Units)
  • Table 49. US & Canada RNA Therapeutics and Vaccines Sales by Type (2024-2029) & (K Units)
  • Table 50. US & Canada RNA Therapeutics and Vaccines Revenue by Type (2018-2023) & (US$ Million)
  • Table 51. US & Canada RNA Therapeutics and Vaccines Revenue by Type (2024-2029) & (US$ Million)
  • Table 52. US & Canada RNA Therapeutics and Vaccines Sales by Application (2018-2023) & (K Units)
  • Table 53. US & Canada RNA Therapeutics and Vaccines Sales by Application (2024-2029) & (K Units)
  • Table 54. US & Canada RNA Therapeutics and Vaccines Revenue by Application (2018-2023) & (US$ Million)
  • Table 55. US & Canada RNA Therapeutics and Vaccines Revenue by Application (2024-2029) & (US$ Million)
  • Table 56. US & Canada RNA Therapeutics and Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 57. US & Canada RNA Therapeutics and Vaccines Revenue by Country (2018-2023) & (US$ Million)
  • Table 58. US & Canada RNA Therapeutics and Vaccines Revenue by Country (2024-2029) & (US$ Million)
  • Table 59. US & Canada RNA Therapeutics and Vaccines Sales by Country (2018-2023) & (K Units)
  • Table 60. US & Canada RNA Therapeutics and Vaccines Sales by Country (2024-2029) & (K Units)
  • Table 61. Europe RNA Therapeutics and Vaccines Sales by Type (2018-2023) & (K Units)
  • Table 62. Europe RNA Therapeutics and Vaccines Sales by Type (2024-2029) & (K Units)
  • Table 63. Europe RNA Therapeutics and Vaccines Revenue by Type (2018-2023) & (US$ Million)
  • Table 64. Europe RNA Therapeutics and Vaccines Revenue by Type (2024-2029) & (US$ Million)
  • Table 65. Europe RNA Therapeutics and Vaccines Sales by Application (2018-2023) & (K Units)
  • Table 66. Europe RNA Therapeutics and Vaccines Sales by Application (2024-2029) & (K Units)
  • Table 67. Europe RNA Therapeutics and Vaccines Revenue by Application (2018-2023) & (US$ Million)
  • Table 68. Europe RNA Therapeutics and Vaccines Revenue by Application (2024-2029) & (US$ Million)
  • Table 69. Europe RNA Therapeutics and Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 70. Europe RNA Therapeutics and Vaccines Revenue by Country (2018-2023) & (US$ Million)
  • Table 71. Europe RNA Therapeutics and Vaccines Revenue by Country (2024-2029) & (US$ Million)
  • Table 72. Europe RNA Therapeutics and Vaccines Sales by Country (2018-2023) & (K Units)
  • Table 73. Europe RNA Therapeutics and Vaccines Sales by Country (2024-2029) & (K Units)
  • Table 74. China RNA Therapeutics and Vaccines Sales by Type (2018-2023) & (K Units)
  • Table 75. China RNA Therapeutics and Vaccines Sales by Type (2024-2029) & (K Units)
  • Table 76. China RNA Therapeutics and Vaccines Revenue by Type (2018-2023) & (US$ Million)
  • Table 77. China RNA Therapeutics and Vaccines Revenue by Type (2024-2029) & (US$ Million)
  • Table 78. China RNA Therapeutics and Vaccines Sales by Application (2018-2023) & (K Units)
  • Table 79. China RNA Therapeutics and Vaccines Sales by Application (2024-2029) & (K Units)
  • Table 80. China RNA Therapeutics and Vaccines Revenue by Application (2018-2023) & (US$ Million)
  • Table 81. China RNA Therapeutics and Vaccines Revenue by Application (2024-2029) & (US$ Million)
  • Table 82. Asia RNA Therapeutics and Vaccines Sales by Type (2018-2023) & (K Units)
  • Table 83. Asia RNA Therapeutics and Vaccines Sales by Type (2024-2029) & (K Units)
  • Table 84. Asia RNA Therapeutics and Vaccines Revenue by Type (2018-2023) & (US$ Million)
  • Table 85. Asia RNA Therapeutics and Vaccines Revenue by Type (2024-2029) & (US$ Million)
  • Table 86. Asia RNA Therapeutics and Vaccines Sales by Application (2018-2023) & (K Units)
  • Table 87. Asia RNA Therapeutics and Vaccines Sales by Application (2024-2029) & (K Units)
  • Table 88. Asia RNA Therapeutics and Vaccines Revenue by Application (2018-2023) & (US$ Million)
  • Table 89. Asia RNA Therapeutics and Vaccines Revenue by Application (2024-2029) & (US$ Million)
  • Table 90. Asia RNA Therapeutics and Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 91. Asia RNA Therapeutics and Vaccines Revenue by Region (2018-2023) & (US$ Million)
  • Table 92. Asia RNA Therapeutics and Vaccines Revenue by Region (2024-2029) & (US$ Million)
  • Table 93. Asia RNA Therapeutics and Vaccines Sales by Region (2018-2023) & (K Units)
  • Table 94. Asia RNA Therapeutics and Vaccines Sales by Region (2024-2029) & (K Units)
  • Table 95. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Sales by Type (2018-2023) & (K Units)
  • Table 96. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Sales by Type (2024-2029) & (K Units)
  • Table 97. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Revenue by Type (2018-2023) & (US$ Million)
  • Table 98. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Revenue by Type (2024-2029) & (US$ Million)
  • Table 99. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Sales by Application (2018-2023) & (K Units)
  • Table 100. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Sales by Application (2024-2029) & (K Units)
  • Table 101. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Revenue by Application (2018-2023) & (US$ Million)
  • Table 102. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Revenue by Application (2024-2029) & (US$ Million)
  • Table 103. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 104. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Revenue by Country (2018-2023) & (US$ Million)
  • Table 105. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Revenue by Country (2024-2029) & (US$ Million)
  • Table 106. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Sales by Country (2018-2023) & (K Units)
  • Table 107. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Sales by Country (2024-2029) & (K Units)
  • Table 108. Moderna Company Information
  • Table 109. Moderna Description and Major Businesses
  • Table 110. Moderna RNA Therapeutics and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 111. Moderna RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 112. Moderna Recent Developments
  • Table 113. BioNTech (Pfizer) Company Information
  • Table 114. BioNTech (Pfizer) Description and Major Businesses
  • Table 115. BioNTech (Pfizer) RNA Therapeutics and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 116. BioNTech (Pfizer) RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 117. BioNTech (Pfizer) Recent Developments
  • Table 118. Sanofi Company Information
  • Table 119. Sanofi Description and Major Businesses
  • Table 120. Sanofi RNA Therapeutics and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 121. Sanofi RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 122. Sanofi Recent Developments
  • Table 123. Novartis Company Information
  • Table 124. Novartis Description and Major Businesses
  • Table 125. Novartis RNA Therapeutics and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 126. Novartis RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 127. Novartis Recent Developments
  • Table 128. CureVac Company Information
  • Table 129. CureVac Description and Major Businesses
  • Table 130. CureVac RNA Therapeutics and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 131. CureVac RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 132. CureVac Recent Developments
  • Table 133. CSL Company Information
  • Table 134. CSL Description and Major Businesses
  • Table 135. CSL RNA Therapeutics and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 136. CSL RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 137. CSL Recent Developments
  • Table 138. Arrowhead Pharmaceuticals Company Information
  • Table 139. Arrowhead Pharmaceuticals Description and Major Businesses
  • Table 140. Arrowhead Pharmaceuticals RNA Therapeutics and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 141. Arrowhead Pharmaceuticals RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 142. Arrowhead Pharmaceuticals Recent Developments
  • Table 143. Alnylam Pharmaceuticals Company Information
  • Table 144. Alnylam Pharmaceuticals Description and Major Businesses
  • Table 145. Alnylam Pharmaceuticals RNA Therapeutics and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 146. Alnylam Pharmaceuticals RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 147. Alnylam Pharmaceuticals Recent Developments
  • Table 148. GlaxoSmithKline (GSK) Company Information
  • Table 149. GlaxoSmithKline (GSK) Description and Major Businesses
  • Table 150. GlaxoSmithKline (GSK) RNA Therapeutics and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 151. GlaxoSmithKline (GSK) RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 152. GlaxoSmithKline (GSK) Recent Developments
  • Table 153. Ionis Pharmaceuticals Company Information
  • Table 154. Ionis Pharmaceuticals Description and Major Businesses
  • Table 155. Ionis Pharmaceuticals RNA Therapeutics and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 156. Ionis Pharmaceuticals RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 157. Ionis Pharmaceuticals Recent Developments
  • Table 158. Regulus Therapeutics Company Information
  • Table 159. Regulus Therapeutics Description and Major Businesses
  • Table 160. Regulus Therapeutics RNA Therapeutics and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 161. Regulus Therapeutics RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 162. Regulus Therapeutics Recent Developments
  • Table 163. Roche Company Information
  • Table 164. Roche Description and Major Businesses
  • Table 165. Roche RNA Therapeutics and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 166. Roche RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 167. Roche Recent Developments
  • Table 168. AstraZeneca Company Information
  • Table 169. AstraZeneca Description and Major Businesses
  • Table 170. AstraZeneca RNA Therapeutics and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 171. AstraZeneca RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 172. AstraZeneca Recent Developments
  • Table 173. Sarepta Therapeutics Company Information
  • Table 174. Sarepta Therapeutics Description and Major Businesses
  • Table 175. Sarepta Therapeutics RNA Therapeutics and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 176. Sarepta Therapeutics RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 177. Sarepta Therapeutics Recent Developments
  • Table 178. Orna Therapeutics Company Information
  • Table 179. Orna Therapeutics Description and Major Businesses
  • Table 180. Orna Therapeutics RNA Therapeutics and Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 181. Orna Therapeutics RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 182. Orna Therapeutics Recent Developments
  • Table 183. Key Raw Materials Lists
  • Table 184. Raw Materials Key Suppliers Lists
  • Table 185. RNA Therapeutics and Vaccines Distributors List
  • Table 186. RNA Therapeutics and Vaccines Customers List
  • Table 187. RNA Therapeutics and Vaccines Market Trends
  • Table 188. RNA Therapeutics and Vaccines Market Drivers
  • Table 189. RNA Therapeutics and Vaccines Market Challenges
  • Table 190. RNA Therapeutics and Vaccines Market Restraints
  • Table 191. Research Programs/Design for This Report
  • Table 192. Key Data Information from Secondary Sources
  • Table 193. Key Data Information from Primary Sources

List of Figures

  • Figure 1. RNA Therapeutics and Vaccines Product Picture
  • Figure 2. Global RNA Therapeutics and Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global RNA Therapeutics and Vaccines Market Share by Type in 2022 & 2029
  • Figure 4. mRNA (messenger RNA) Therapeutics Product Picture
  • Figure 5. siRNA (small interfering RNA) Therapeutics Product Picture
  • Figure 6. Antisense Oligonucleotide Therapeutics Product Picture
  • Figure 7. Global RNA Therapeutics and Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 8. Global RNA Therapeutics and Vaccines Market Share by Application in 2022 & 2029
  • Figure 9. Hospitals
  • Figure 10. Research Institutions
  • Figure 11. RNA Therapeutics and Vaccines Report Years Considered
  • Figure 12. Global RNA Therapeutics and Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 13. Global RNA Therapeutics and Vaccines Revenue 2018-2029 (US$ Million)
  • Figure 14. Global RNA Therapeutics and Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2029
  • Figure 15. Global RNA Therapeutics and Vaccines Revenue Market Share by Region (2018-2029)
  • Figure 16. Global RNA Therapeutics and Vaccines Sales 2018-2029 ((K Units)
  • Figure 17. Global RNA Therapeutics and Vaccines Sales Market Share by Region (2018-2029)
  • Figure 18. US & Canada RNA Therapeutics and Vaccines Sales YoY (2018-2029) & (K Units)
  • Figure 19. US & Canada RNA Therapeutics and Vaccines Revenue YoY (2018-2029) & (US$ Million)
  • Figure 20. Europe RNA Therapeutics and Vaccines Sales YoY (2018-2029) & (K Units)
  • Figure 21. Europe RNA Therapeutics and Vaccines Revenue YoY (2018-2029) & (US$ Million)
  • Figure 22. China RNA Therapeutics and Vaccines Sales YoY (2018-2029) & (K Units)
  • Figure 23. China RNA Therapeutics and Vaccines Revenue YoY (2018-2029) & (US$ Million)
  • Figure 24. Asia (excluding China) RNA Therapeutics and Vaccines Sales YoY (2018-2029) & (K Units)
  • Figure 25. Asia (excluding China) RNA Therapeutics and Vaccines Revenue YoY (2018-2029) & (US$ Million)
  • Figure 26. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Sales YoY (2018-2029) & (K Units)
  • Figure 27. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Revenue YoY (2018-2029) & (US$ Million)
  • Figure 28. The RNA Therapeutics and Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
  • Figure 29. The Top 5 and 10 Largest Manufacturers of RNA Therapeutics and Vaccines in the World: Market Share by RNA Therapeutics and Vaccines Revenue in 2022
  • Figure 30. Global RNA Therapeutics and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
  • Figure 31. Global RNA Therapeutics and Vaccines Sales Market Share by Type (2018-2029)
  • Figure 32. Global RNA Therapeutics and Vaccines Revenue Market Share by Type (2018-2029)
  • Figure 33. Global RNA Therapeutics and Vaccines Sales Market Share by Application (2018-2029)
  • Figure 34. Global RNA Therapeutics and Vaccines Revenue Market Share by Application (2018-2029)
  • Figure 35. US & Canada RNA Therapeutics and Vaccines Sales Market Share by Type (2018-2029)
  • Figure 36. US & Canada RNA Therapeutics and Vaccines Revenue Market Share by Type (2018-2029)
  • Figure 37. US & Canada RNA Therapeutics and Vaccines Sales Market Share by Application (2018-2029)
  • Figure 38. US & Canada RNA Therapeutics and Vaccines Revenue Market Share by Application (2018-2029)
  • Figure 39. US & Canada RNA Therapeutics and Vaccines Revenue Share by Country (2018-2029)
  • Figure 40. US & Canada RNA Therapeutics and Vaccines Sales Share by Country (2018-2029)
  • Figure 41. U.S. RNA Therapeutics and Vaccines Revenue (2018-2029) & (US$ Million)
  • Figure 42. Canada RNA Therapeutics and Vaccines Revenue (2018-2029) & (US$ Million)
  • Figure 43. Europe RNA Therapeutics and Vaccines Sales Market Share by Type (2018-2029)
  • Figure 44. Europe RNA Therapeutics and Vaccines Revenue Market Share by Type (2018-2029)
  • Figure 45. Europe RNA Therapeutics and Vaccines Sales Market Share by Application (2018-2029)
  • Figure 46. Europe RNA Therapeutics and Vaccines Revenue Market Share by Application (2018-2029)
  • Figure 47. Europe RNA Therapeutics and Vaccines Revenue Share by Country (2018-2029)
  • Figure 48. Europe RNA Therapeutics and Vaccines Sales Share by Country (2018-2029)
  • Figure 49. Germany RNA Therapeutics and Vaccines Revenue (2018-2029) & (US$ Million)
  • Figure 50. France RNA Therapeutics and Vaccines Revenue (2018-2029) & (US$ Million)
  • Figure 51. U.K. RNA Therapeutics and Vaccines Revenue (2018-2029) & (US$ Million)
  • Figure 52. Italy RNA Therapeutics and Vaccines Revenue (2018-2029) & (US$ Million)
  • Figure 53. Russia RNA Therapeutics and Vaccines Revenue (2018-2029) & (US$ Million)
  • Figure 54. China RNA Therapeutics and Vaccines Sales Market Share by Type (2018-2029)
  • Figure 55. China RNA Therapeutics and Vaccines Revenue Market Share by Type (2018-2029)
  • Figure 56. China RNA Therapeutics and Vaccines Sales Market Share by Application (2018-2029)
  • Figure 57. China RNA Therapeutics and Vaccines Revenue Market Share by Application (2018-2029)
  • Figure 58. Asia RNA Therapeutics and Vaccines Sales Market Share by Type (2018-2029)
  • Figure 59. Asia RNA Therapeutics and Vaccines Revenue Market Share by Type (2018-2029)
  • Figure 60. Asia RNA Therapeutics and Vaccines Sales Market Share by Application (2018-2029)
  • Figure 61. Asia RNA Therapeutics and Vaccines Revenue Market Share by Application (2018-2029)
  • Figure 62. Asia RNA Therapeutics and Vaccines Revenue Share by Region (2018-2029)
  • Figure 63. Asia RNA Therapeutics and Vaccines Sales Share by Region (2018-2029)
  • Figure 64. Japan RNA Therapeutics and Vaccines Revenue (2018-2029) & (US$ Million)
  • Figure 65. South Korea RNA Therapeutics and Vaccines Revenue (2018-2029) & (US$ Million)
  • Figure 66. China Taiwan RNA Therapeutics and Vaccines Revenue (2018-2029) & (US$ Million)
  • Figure 67. Southeast Asia RNA Therapeutics and Vaccines Revenue (2018-2029) & (US$ Million)
  • Figure 68. India RNA Therapeutics and Vaccines Revenue (2018-2029) & (US$ Million)
  • Figure 69. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Sales Market Share by Type (2018-2029)
  • Figure 70. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Revenue Market Share by Type (2018-2029)
  • Figure 71. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Sales Market Share by Application (2018-2029)
  • Figure 72. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Revenue Market Share by Application (2018-2029)
  • Figure 73. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Revenue Share by Country (2018-2029)
  • Figure 74. Middle East, Africa and Latin America RNA Therapeutics and Vaccines Sales Share by Country (2018-2029)
  • Figure 75. Brazil RNA Therapeutics and Vaccines Revenue (2018-2029) & (US$ Million)
  • Figure 76. Mexico RNA Therapeutics and Vaccines Revenue (2018-2029) & (US$ Million)
  • Figure 77. Turkey RNA Therapeutics and Vaccines Revenue (2018-2029) & (US$ Million)
  • Figure 78. Israel RNA Therapeutics and Vaccines Revenue (2018-2029) & (US$ Million)
  • Figure 79. GCC Countries RNA Therapeutics and Vaccines Revenue (2018-2029) & (US$ Million)
  • Figure 80. RNA Therapeutics and Vaccines Value Chain
  • Figure 81. RNA Therapeutics and Vaccines Production Process
  • Figure 82. Channels of Distribution
  • Figure 83. Distributors Profiles
  • Figure 84. Bottom-up and Top-down Approaches for This Report
  • Figure 85. Data Triangulation
  • Figure 86. Key Executives Interviewed
目次

This research report focuses on the RNA Therapeutics and Vaccines Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 RNA Therapeutics and Vaccines Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global RNA Therapeutics and Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 mRNA (messenger RNA) Therapeutics
    • 1.2.3 siRNA (small interfering RNA) Therapeutics
    • 1.2.4 Antisense Oligonucleotide Therapeutics
  • 1.3 Market by Application
    • 1.3.1 Global RNA Therapeutics and Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Hospitals
    • 1.3.3 Research Institutions
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global RNA Therapeutics and Vaccines Sales Estimates and Forecasts 2018-2029
  • 2.2 Global RNA Therapeutics and Vaccines Revenue by Region
    • 2.2.1 Global RNA Therapeutics and Vaccines Revenue by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Global RNA Therapeutics and Vaccines Revenue by Region (2018-2023)
    • 2.2.3 Global RNA Therapeutics and Vaccines Revenue by Region (2024-2029)
    • 2.2.4 Global RNA Therapeutics and Vaccines Revenue Market Share by Region (2018-2029)
  • 2.3 Global RNA Therapeutics and Vaccines Sales Estimates and Forecasts 2018-2029
  • 2.4 Global RNA Therapeutics and Vaccines Sales by Region
    • 2.4.1 Global RNA Therapeutics and Vaccines Sales by Region: 2018 VS 2022 VS 2029
    • 2.4.2 Global RNA Therapeutics and Vaccines Sales by Region (2018-2023)
    • 2.4.3 Global RNA Therapeutics and Vaccines Sales by Region (2024-2029)
    • 2.4.4 Global RNA Therapeutics and Vaccines Sales Market Share by Region (2018-2029)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

  • 3.1 Global RNA Therapeutics and Vaccines Sales by Manufacturers
    • 3.1.1 Global RNA Therapeutics and Vaccines Sales by Manufacturers (2018-2023)
    • 3.1.2 Global RNA Therapeutics and Vaccines Sales Market Share by Manufacturers (2018-2023)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of RNA Therapeutics and Vaccines in 2022
  • 3.2 Global RNA Therapeutics and Vaccines Revenue by Manufacturers
    • 3.2.1 Global RNA Therapeutics and Vaccines Revenue by Manufacturers (2018-2023)
    • 3.2.2 Global RNA Therapeutics and Vaccines Revenue Market Share by Manufacturers (2018-2023)
    • 3.2.3 Global Top 10 and Top 5 Companies by RNA Therapeutics and Vaccines Revenue in 2022
  • 3.3 Global Key Players of RNA Therapeutics and Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
  • 3.4 Global RNA Therapeutics and Vaccines Sales Price by Manufacturers
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global RNA Therapeutics and Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of RNA Therapeutics and Vaccines, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of RNA Therapeutics and Vaccines, Product Offered and Application
  • 3.8 Global Key Manufacturers of RNA Therapeutics and Vaccines, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global RNA Therapeutics and Vaccines Sales by Type
    • 4.1.1 Global RNA Therapeutics and Vaccines Historical Sales by Type (2018-2023)
    • 4.1.2 Global RNA Therapeutics and Vaccines Forecasted Sales by Type (2024-2029)
    • 4.1.3 Global RNA Therapeutics and Vaccines Sales Market Share by Type (2018-2029)
  • 4.2 Global RNA Therapeutics and Vaccines Revenue by Type
    • 4.2.1 Global RNA Therapeutics and Vaccines Historical Revenue by Type (2018-2023)
    • 4.2.2 Global RNA Therapeutics and Vaccines Forecasted Revenue by Type (2024-2029)
    • 4.2.3 Global RNA Therapeutics and Vaccines Revenue Market Share by Type (2018-2029)
  • 4.3 Global RNA Therapeutics and Vaccines Price by Type
    • 4.3.1 Global RNA Therapeutics and Vaccines Price by Type (2018-2023)
    • 4.3.2 Global RNA Therapeutics and Vaccines Price Forecast by Type (2024-2029)

5 Market Size by Application

  • 5.1 Global RNA Therapeutics and Vaccines Sales by Application
    • 5.1.1 Global RNA Therapeutics and Vaccines Historical Sales by Application (2018-2023)
    • 5.1.2 Global RNA Therapeutics and Vaccines Forecasted Sales by Application (2024-2029)
    • 5.1.3 Global RNA Therapeutics and Vaccines Sales Market Share by Application (2018-2029)
  • 5.2 Global RNA Therapeutics and Vaccines Revenue by Application
    • 5.2.1 Global RNA Therapeutics and Vaccines Historical Revenue by Application (2018-2023)
    • 5.2.2 Global RNA Therapeutics and Vaccines Forecasted Revenue by Application (2024-2029)
    • 5.2.3 Global RNA Therapeutics and Vaccines Revenue Market Share by Application (2018-2029)
  • 5.3 Global RNA Therapeutics and Vaccines Price by Application
    • 5.3.1 Global RNA Therapeutics and Vaccines Price by Application (2018-2023)
    • 5.3.2 Global RNA Therapeutics and Vaccines Price Forecast by Application (2024-2029)

6 US & Canada

  • 6.1 US & Canada RNA Therapeutics and Vaccines Market Size by Type
    • 6.1.1 US & Canada RNA Therapeutics and Vaccines Sales by Type (2018-2029)
    • 6.1.2 US & Canada RNA Therapeutics and Vaccines Revenue by Type (2018-2029)
  • 6.2 US & Canada RNA Therapeutics and Vaccines Market Size by Application
    • 6.2.1 US & Canada RNA Therapeutics and Vaccines Sales by Application (2018-2029)
    • 6.2.2 US & Canada RNA Therapeutics and Vaccines Revenue by Application (2018-2029)
  • 6.3 US & Canada RNA Therapeutics and Vaccines Market Size by Country
    • 6.3.1 US & Canada RNA Therapeutics and Vaccines Revenue by Country: 2018 VS 2022 VS 2029
    • 6.3.2 US & Canada RNA Therapeutics and Vaccines Sales by Country (2018-2029)
    • 6.3.3 US & Canada RNA Therapeutics and Vaccines Revenue by Country (2018-2029)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe RNA Therapeutics and Vaccines Market Size by Type
    • 7.1.1 Europe RNA Therapeutics and Vaccines Sales by Type (2018-2029)
    • 7.1.2 Europe RNA Therapeutics and Vaccines Revenue by Type (2018-2029)
  • 7.2 Europe RNA Therapeutics and Vaccines Market Size by Application
    • 7.2.1 Europe RNA Therapeutics and Vaccines Sales by Application (2018-2029)
    • 7.2.2 Europe RNA Therapeutics and Vaccines Revenue by Application (2018-2029)
  • 7.3 Europe RNA Therapeutics and Vaccines Market Size by Country
    • 7.3.1 Europe RNA Therapeutics and Vaccines Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 Europe RNA Therapeutics and Vaccines Sales by Country (2018-2029)
    • 7.3.3 Europe RNA Therapeutics and Vaccines Revenue by Country (2018-2029)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China RNA Therapeutics and Vaccines Market Size
    • 8.1.1 China RNA Therapeutics and Vaccines Sales (2018-2029)
    • 8.1.2 China RNA Therapeutics and Vaccines Revenue (2018-2029)
  • 8.2 China RNA Therapeutics and Vaccines Market Size by Application
    • 8.2.1 China RNA Therapeutics and Vaccines Sales by Application (2018-2029)
    • 8.2.2 China RNA Therapeutics and Vaccines Revenue by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia RNA Therapeutics and Vaccines Market Size by Type
    • 9.1.1 Asia RNA Therapeutics and Vaccines Sales by Type (2018-2029)
    • 9.1.2 Asia RNA Therapeutics and Vaccines Revenue by Type (2018-2029)
  • 9.2 Asia RNA Therapeutics and Vaccines Market Size by Application
    • 9.2.1 Asia RNA Therapeutics and Vaccines Sales by Application (2018-2029)
    • 9.2.2 Asia RNA Therapeutics and Vaccines Revenue by Application (2018-2029)
  • 9.3 Asia RNA Therapeutics and Vaccines Sales by Region
    • 9.3.1 Asia RNA Therapeutics and Vaccines Revenue by Region: 2018 VS 2022 VS 2029
    • 9.3.2 Asia RNA Therapeutics and Vaccines Revenue by Region (2018-2029)
    • 9.3.3 Asia RNA Therapeutics and Vaccines Sales by Region (2018-2029)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America RNA Therapeutics and Vaccines Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America RNA Therapeutics and Vaccines Sales by Type (2018-2029)
    • 10.1.2 Middle East, Africa and Latin America RNA Therapeutics and Vaccines Revenue by Type (2018-2029)
  • 10.2 Middle East, Africa and Latin America RNA Therapeutics and Vaccines Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America RNA Therapeutics and Vaccines Sales by Application (2018-2029)
    • 10.2.2 Middle East, Africa and Latin America RNA Therapeutics and Vaccines Revenue by Application (2018-2029)
  • 10.3 Middle East, Africa and Latin America RNA Therapeutics and Vaccines Sales by Country
    • 10.3.1 Middle East, Africa and Latin America RNA Therapeutics and Vaccines Revenue by Country: 2018 VS 2022 VS 2029
    • 10.3.2 Middle East, Africa and Latin America RNA Therapeutics and Vaccines Revenue by Country (2018-2029)
    • 10.3.3 Middle East, Africa and Latin America RNA Therapeutics and Vaccines Sales by Country (2018-2029)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Company Profiles

  • 11.1 Moderna
    • 11.1.1 Moderna Company Information
    • 11.1.2 Moderna Overview
    • 11.1.3 Moderna RNA Therapeutics and Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.1.4 Moderna RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Moderna Recent Developments
  • 11.2 BioNTech (Pfizer)
    • 11.2.1 BioNTech (Pfizer) Company Information
    • 11.2.2 BioNTech (Pfizer) Overview
    • 11.2.3 BioNTech (Pfizer) RNA Therapeutics and Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.2.4 BioNTech (Pfizer) RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 BioNTech (Pfizer) Recent Developments
  • 11.3 Sanofi
    • 11.3.1 Sanofi Company Information
    • 11.3.2 Sanofi Overview
    • 11.3.3 Sanofi RNA Therapeutics and Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.3.4 Sanofi RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Sanofi Recent Developments
  • 11.4 Novartis
    • 11.4.1 Novartis Company Information
    • 11.4.2 Novartis Overview
    • 11.4.3 Novartis RNA Therapeutics and Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.4.4 Novartis RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Novartis Recent Developments
  • 11.5 CureVac
    • 11.5.1 CureVac Company Information
    • 11.5.2 CureVac Overview
    • 11.5.3 CureVac RNA Therapeutics and Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.5.4 CureVac RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 CureVac Recent Developments
  • 11.6 CSL
    • 11.6.1 CSL Company Information
    • 11.6.2 CSL Overview
    • 11.6.3 CSL RNA Therapeutics and Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.6.4 CSL RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 CSL Recent Developments
  • 11.7 Arrowhead Pharmaceuticals
    • 11.7.1 Arrowhead Pharmaceuticals Company Information
    • 11.7.2 Arrowhead Pharmaceuticals Overview
    • 11.7.3 Arrowhead Pharmaceuticals RNA Therapeutics and Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.7.4 Arrowhead Pharmaceuticals RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Arrowhead Pharmaceuticals Recent Developments
  • 11.8 Alnylam Pharmaceuticals
    • 11.8.1 Alnylam Pharmaceuticals Company Information
    • 11.8.2 Alnylam Pharmaceuticals Overview
    • 11.8.3 Alnylam Pharmaceuticals RNA Therapeutics and Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.8.4 Alnylam Pharmaceuticals RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Alnylam Pharmaceuticals Recent Developments
  • 11.9 GlaxoSmithKline (GSK)
    • 11.9.1 GlaxoSmithKline (GSK) Company Information
    • 11.9.2 GlaxoSmithKline (GSK) Overview
    • 11.9.3 GlaxoSmithKline (GSK) RNA Therapeutics and Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.9.4 GlaxoSmithKline (GSK) RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 GlaxoSmithKline (GSK) Recent Developments
  • 11.10 Ionis Pharmaceuticals
    • 11.10.1 Ionis Pharmaceuticals Company Information
    • 11.10.2 Ionis Pharmaceuticals Overview
    • 11.10.3 Ionis Pharmaceuticals RNA Therapeutics and Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.10.4 Ionis Pharmaceuticals RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Ionis Pharmaceuticals Recent Developments
  • 11.11 Regulus Therapeutics
    • 11.11.1 Regulus Therapeutics Company Information
    • 11.11.2 Regulus Therapeutics Overview
    • 11.11.3 Regulus Therapeutics RNA Therapeutics and Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.11.4 Regulus Therapeutics RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 Regulus Therapeutics Recent Developments
  • 11.12 Roche
    • 11.12.1 Roche Company Information
    • 11.12.2 Roche Overview
    • 11.12.3 Roche RNA Therapeutics and Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.12.4 Roche RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Roche Recent Developments
  • 11.13 AstraZeneca
    • 11.13.1 AstraZeneca Company Information
    • 11.13.2 AstraZeneca Overview
    • 11.13.3 AstraZeneca RNA Therapeutics and Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.13.4 AstraZeneca RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.13.5 AstraZeneca Recent Developments
  • 11.14 Sarepta Therapeutics
    • 11.14.1 Sarepta Therapeutics Company Information
    • 11.14.2 Sarepta Therapeutics Overview
    • 11.14.3 Sarepta Therapeutics RNA Therapeutics and Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.14.4 Sarepta Therapeutics RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.14.5 Sarepta Therapeutics Recent Developments
  • 11.15 Orna Therapeutics
    • 11.15.1 Orna Therapeutics Company Information
    • 11.15.2 Orna Therapeutics Overview
    • 11.15.3 Orna Therapeutics RNA Therapeutics and Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.15.4 Orna Therapeutics RNA Therapeutics and Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.15.5 Orna Therapeutics Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 RNA Therapeutics and Vaccines Industry Chain Analysis
  • 12.2 RNA Therapeutics and Vaccines Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 RNA Therapeutics and Vaccines Production Mode & Process
  • 12.4 RNA Therapeutics and Vaccines Sales and Marketing
    • 12.4.1 RNA Therapeutics and Vaccines Sales Channels
    • 12.4.2 RNA Therapeutics and Vaccines Distributors
  • 12.5 RNA Therapeutics and Vaccines Customers

13 Market Dynamics

  • 13.1 RNA Therapeutics and Vaccines Industry Trends
  • 13.2 RNA Therapeutics and Vaccines Market Drivers
  • 13.3 RNA Therapeutics and Vaccines Market Challenges
  • 13.4 RNA Therapeutics and Vaccines Market Restraints

14 Key Findings in The Global RNA Therapeutics and Vaccines Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer